If the last few years have taught us anything, it’s that even the best strategy can crumble under sustained volatility. Resilience must become an operating strategy.

Lerodalcibep is currently under regulatory review by both the European Medicines Agency (EMA).‌ In Greater China, Biologics License Application (BLA) submission is expected in 1H 2026, with the ...

Explore Hautlence's innovative timepieces that blend mechanics with striking design for a captivating watchmaking experience.

Valve has been the master of first impressions since its debut game. Half-Life's opening level, Black Mesa Inbound, is one of the most iconic missions in all of gaming. Valve drops the player on ...

First study participant dosed in U.S. trial with healthy volunteers and patients with peanut allergy Novel, human-derived, half-life extended ...

Vir Biotechnology, Inc. today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive license for ...

Also in the 1990s, Collins and colleague Saed Mirzadeh, a now-retired distinguished staff scientist and ORNL Corporate Fellow ...

There’s a moment every founder hits where the noise gets loud. Competitors raise a round. A friend’s startup goes viral on ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

According to research by SNS Insider, the U.S. Antibody Discovery Market is projected to grow at a CAGR of 8.13%, fueled by expanding biologics pipelines, strategic collaborations, and increased ...

Orano Med's collaboration with Roche to develop "two-step pretargeted radioimmunotherapy" (or PRIT) ready to advance into clinical development.

Detailed price information for Ventripoint Diagnostics Ltd (VPT-X) from The Globe and Mail including charting and trades.